company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,335500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,335500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,101900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,101900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,233600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,128500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,172600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,61000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,62800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,47500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,47500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,47500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.41
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 16:17:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,325700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,325700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,98500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,98500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,227200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,126100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-38200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,132600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,94600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,94200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,73500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,73500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,73500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.65
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.63
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:52:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.65
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,340500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,340500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,98600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,98600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,241900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,134000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,179200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,62700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,65500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,47700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,47700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,47700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,365200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,365200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,100400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,100400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,264800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,140600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,50600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,8300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,199500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,65300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,66400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,57500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,57500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,57500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.48
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,112700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:12:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,348900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,348900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,95800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,95800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,253100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,133000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,189600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,63500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,66200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,48000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,48000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:11:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,392400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,392400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,113500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,113500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,278900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,142400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,55900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-8100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,10500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,200700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,78200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,70100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,64800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,64800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,64800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,404500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,404500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,116800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,116800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,287700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,150300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,59000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,209300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,78400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,84600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,63900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,63900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.56
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,120500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.53
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.56
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,431200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,431200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,127800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,127800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,303400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,163200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,64900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,232100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,71300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,72800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,58100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,58100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,58100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,120000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.48
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 19:11:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,412700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,412700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,125600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,125600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,287100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,165500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,61700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,227200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,59900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,57600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,51600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,51600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,51600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.45
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 19:29:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.45
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,430200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,430200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,119600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,119600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,310600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,163400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,60700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-4800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,17600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,236900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,73700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,68600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,63100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,63100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.55
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.55
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.55
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,459200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,459200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,127300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,127300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,331900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,177200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,68600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,246300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,85600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,85600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,65100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,65100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,65100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.55
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,482000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,482000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,129800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,129800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,352200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,182400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,74000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,262400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,89800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,89900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,22100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,67800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,67800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,67800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:00:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,447900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,447900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,111700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,111700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,336200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,167800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,73800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,243100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,93100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,93400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,24200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,69200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,69200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,69200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,115700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.6
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,119000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.58
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,115300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,2013-11-07 17:02:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.6
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,510500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,510500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,122200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,122200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,388300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,170000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,74900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,23400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,269000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,119300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,119300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,89400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,89400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,89400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,114900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.78
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,118300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.78
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,114300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.78
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,496700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,496700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,121000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,121000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,375700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,182400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,79800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-78100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,185300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,190400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,190600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,46700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,143900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,143900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,143900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.26
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.24
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,113300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.27
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,517200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,517200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,123600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,123600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,393600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,186600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,80500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,5500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,272700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,120900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,120500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,27200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,93300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,93300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,93300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.83
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,114700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.81
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,112400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,2014-08-04 16:04:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.83
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,495600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,495600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,128200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,128200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,367400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,177800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,84100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,266600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,100800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,99800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,23000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,76800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,76800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,76800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,111000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.69
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,112900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.68
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,111300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,2014-10-31 16:06:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.69
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,536000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,536000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,143800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,143800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,392200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,186600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,78600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,23100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,287900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,104300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,100300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,25200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,75100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,75100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,75100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,223400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,227600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,522400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,522400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,145900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,145900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,376500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,197200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,85800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,13000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,295700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,80800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,77300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,60300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,60300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,60300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,108500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,575100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,575100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,151200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,151200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,423900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,215500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,89100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-697400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-392400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,816300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,813200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,266200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,547000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,547000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,547000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,105600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.18
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,107400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.09
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,2015-07-29 16:10:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.18
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,607400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,607400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,168100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,168100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,439300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,222200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,87600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,316200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,123100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,120600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,94600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,94600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,94600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.89
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,108400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.87
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,106300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,2015-10-28 19:43:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.89
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,618000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,618000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,160400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,160400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,457600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,223100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,84000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,10800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,315300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,142300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,132900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,23700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,109200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,109200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,109200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,213000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,212900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,590300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,590300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,136000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,136000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,454300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,202500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,86400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,289100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,165200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,162500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,39100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,123400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,123400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,123400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,220600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,216500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,616800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,616800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,158600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,158600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,458200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,213900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,97500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,313200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,145000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,142200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,112700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,112700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,112700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,216700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 19:58:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,615500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,615500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,146700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,146700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,468800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,212000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,101000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,313000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,155800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,150700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,32600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,118100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,118100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,118100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.55
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.54
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,214700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 19:47:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.55
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,671100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,671100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,175900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,175900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,495200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,222300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,98000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,325500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,169700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,167000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,140700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,140700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,140700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.65
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,220300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.65
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,215200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.65
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,697300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,697300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,180300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,180300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,517000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,212700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,101800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,12800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,327300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,189700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,183300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,40300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,143000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,143000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,143000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,213100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.67
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.66
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,213400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.67
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,759300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,759300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,202500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,202500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,556800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,228800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,112500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,44000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,385300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,171500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,169000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,42400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,126600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,126600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,126600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,212200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.6
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.58
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,211000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,2017-07-28 16:11:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.6
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,739400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,739400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,201400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,201400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,538000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,229600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,113000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,6600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,349200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,188800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,185200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,43800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,141400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,141400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,141400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,213200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.66
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,218100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.65
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,214200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,2017-10-27 16:11:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.66
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,767700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,767700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,213200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,213200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,554500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,233600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,114900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,353300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,201200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,200400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,41900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,158500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,158500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,158500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,213000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.74
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,217800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.74
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,213300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.74
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,883500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,883500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,215600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,215600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,667900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,229600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,128700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,11300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,369600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,298300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,293600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,63400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,230200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,230200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,230200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,211200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.09
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,216400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.06
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,211200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.09
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,841800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,841800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,211100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,211100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,630700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,243800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,134400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,10800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,389700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,241000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-34000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-35400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,205600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,186100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,186100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,186100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,210500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.88
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.86
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,211500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,2018-07-27 16:07:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.88
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,821500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,821500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,213300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,213300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,608200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,244600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,142900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,394200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,214000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,211800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,41700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,170100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,170100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,170100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,211300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.81
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,216200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.79
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,210000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 20:39:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.81
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,888500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,888500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,235300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,235300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,653200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,272800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,146600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-9700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-92600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,317100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,336100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-13200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,323900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,326700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,210900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,210700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,894800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,894800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,233600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,233600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,661200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,256000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,143200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,9500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,408700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,252500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,11000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,263500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,56900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,206600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,206600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,206600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,210200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.98
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.96
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,210800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.98
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,943700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,943700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,246200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,246200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,697500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,274900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,154100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,16400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,445400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,252100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,251000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-31700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,282700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,282700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,282700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,209500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.35
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,214000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.32
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,209400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,2019-07-26 16:05:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.35
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,906600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,906600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,224900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,224900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,681700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,269500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,161800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,432800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,248900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,248700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,22800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,225900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,225900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,225900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,209000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.08
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,213200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.06
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,209200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,2019-10-25 16:08:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.08
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,977700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,977700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,234700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,234700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,743000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,288100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,163100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,297100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,748300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,30200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,32000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-8800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,209200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,213600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,209300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,993000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,993000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,231800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,231800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,761200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,280300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,171400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,35300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,487000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,274200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,278000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,28300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,249700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,249700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,249700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,207900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.2
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.18
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.2
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1086900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1086900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,304000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,304000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,782900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,308500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,191900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,15000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,515400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,267500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,271300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,242300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,242300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,242300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,208100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.16
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.14
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,2019-07-26 16:05:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.16
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1094000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1094000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,292400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,292400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,801600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,306200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,195500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,5600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,507300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,294300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,301700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,27000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,274700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,274700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,274700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,208200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.32
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.3
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,2019-10-25 16:08:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.32
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1174100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1174100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,286200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,286200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,887900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,347200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,193900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,36000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,577100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,310800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,27900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,32200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,315500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,35300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,280200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,280200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,280200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,208300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.35
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,212200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.31
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,208100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.35
